NurseThink Revenue and Competitors

Victoria, MN USA

Location

N/A

Total Funding

Education

Industry

Estimated Revenue & Valuation

  • NurseThink's estimated annual revenue is currently $540k per year.(i)
  • NurseThink's estimated revenue per employee is $90,000

Employee Data

  • NurseThink has 6 Employees.(i)
  • NurseThink grew their employee count by -45% last year.

NurseThink's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M360%N/AN/A
#2
$540.5M2145N/AN/AN/A
#3
$182.4M7242%N/AN/A
#4
$13.7M769%N/AN/A
#5
$1867.8M74124%N/AN/A
#6
$6.3M44-6%N/AN/A
#7
$30.9M15612%N/AN/A
#8
$9.9M615%N/AN/A
#9
$8.3M5134%N/AN/A
#10
$8.7M54-4%N/AN/A
Add Company

What Is NurseThink?

In 2003 NurseTim®, Inc. was founded by Dr. Tim Bristol with one goal - to be a resource for nurse educators and provide high high quality faculty development solutions that are accessible to all programs. As NurseTim® continued to grow, so did its passion to see not only faculty succeed, but students as well. We want students to not only be successful in the classroom, but on NCLEX® and, most importantly, in practice. In 2016, NurseThink®, a brand of NurseTim®, was born. The whole goal of NurseThink® is to give students the power they need to study and learn more effectively, while providing faculty with Next Gen Learning tools to successfully prepare students for NCLEX® and for Practice Readiness. NurseThink® is all about the development of Clinical Judgment skills in every student across the curriculum. NurseThink® COMPLETE is a complete package that incorporates clinical judgment across the curriculum. From Clinical Judgment Exams to Virtual Patients to NCLEX® PreView & ReView, Next Gen Learning is here with NurseThink® COMPLETE.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$540k

Revenue (est)

-45%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M60%N/A
#2
$0.4M6N/AN/A
#3
$0.9M7N/AN/A
#4
$0.7M70%N/A
#5
N/A80%N/A